We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.72T
| $1.22B | 3.53% |
39,307,048
-759,364
| -2% | -$22.9M |
|
2
ExxonMobil
XOM
$650B
| $573M | 1.65% |
6,744,089
-117,000
| -2% | -$10.4M |
|
3
Microsoft
MSFT
$2.83T
| $549M | 1.58% |
13,505,590
-197,015
| -1% | -$8.58M |
|
4
Alphabet (Google) Class C
GOOG
$3.89T
| $518M | 1.49% |
18,839,221
-138,460
| -0.7% | -$3.71M |
|
5
Johnson & Johnson
JNJ
$624B
| $424M | 1.22% |
4,211,175
-52,590
| -1% | -$5.35M |
|
6
Wells Fargo
WFC
$261B
| $413M | 1.19% |
7,599,046
+24,873
| +0.3% | +$1.34M |
|
7
Berkshire Hathaway Class B
BRK.B
$1.06T
| $412M | 1.19% |
2,856,013
-12,716
| -0.4% | -$1.87M |
|
8
GE Aerospace
GE
$362B
| $359M | 1.04% |
3,021,178
-31,319
| -1% | -$3.73M |
|
9
Procter & Gamble
PG
$342B
| $359M | 1.04% |
4,382,415
-17,420
| -0.4% | -$1.5M |
|
10
JPMorgan Chase
JPM
$930B
| $353M | 1.02% |
5,830,739
-91,817
| -2% | -$5.44M |
|
11
Verizon
VZ
$183B
| $337M | 0.97% |
6,928,020
-64,665
| -0.9% | -$3.12M |
|
12
Pfizer
PFE
$143B
| $326M | 0.94% |
9,865,431
-150,123
| -1% | -$4.77M |
|
13
Chevron
CVX
$387B
| $319M | 0.92% |
3,034,712
-49,853
| -2% | -$5.32M |
|
14
Walt Disney
DIS
$161B
| $281M | 0.81% |
2,677,135
-109,352
| -4% | -$11M |
|
15
Coca-Cola
KO
$349B
| $274M | 0.79% |
6,767,521
-149,962
| -2% | -$6.27M |
|
16
AT&T
T
$157B
| $274M | 0.79% |
11,107,037
-60,584
| -0.5% | -$1.54M |
|
17
Meta Platforms (Facebook)
META
$1.54T
| $272M | 0.78% |
3,307,756
-36,000
| -1% | -$2.82M |
|
18
Home Depot
HD
$324B
| $256M | 0.74% |
2,251,021
-46,624
| -2% | -$5.14M |
|
19
IBM
IBM
$195B
| $253M | 0.73% |
1,649,552
-24,888
| -1% | -$3.77M |
|
20
Bank of America
BAC
$430B
| $253M | 0.73% |
16,428,774
-123,957
| -0.7% | -$1.99M |
|
21
Intel
INTC
$504B
| $248M | 0.72% |
7,931,704
-135,788
| -2% | -$4.58M |
|
22
Gilead Sciences
GILD
$162B
| $245M | 0.71% |
2,499,215
-56,258
| -2% | -$5.71M |
|
23
Citigroup
C
$221B
| $244M | 0.7% |
4,742,696
-35,770
| -0.7% | -$1.82M |
|
24
PepsiCo
PEP
$184B
| $243M | 0.7% |
2,537,268
-53,660
| -2% | -$5.19M |
|
25
Merck
MRK
$322B
| $241M | 0.69% |
4,390,902
-45,582
| -1% | -$2.58M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.